The Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) that is required by the U.S. Food and Drug Administration (FDA) for opioid analgesic drug products used in the outpatient setting, and to provide two helpful resources that are a part of the Opioid Analgesic REMS. We ask you to consider the development and/or distribution of training materials for your practitioners and encourage them to utilize these resources and to successfully complete REMS-compliant training to improve their ability to prescribe these medications more safely.
Under the conditions of the REMS, healthcare providers (HCPs) are strongly encouraged to:
- complete a REMS-compliant education program,
- counsel patients and/or their caregivers with every prescription on the safe use, serious risks, and proper storage and disposal of these products using the Opioid Analgesic REMS Patient Counseling Guide and the specific drug’s Medication Guide, and
- consider other tools to improve patient, household, and community